| Biology of the endothelium T Luscher, M Barton Clinical Cardiology 20 (Suppl. II), 3-10, 1997 | 1311 | 1997 |
| The G-protein-coupled estrogen receptor GPER in health and disease ER Prossnitz, M Barton Nature Reviews Endocrinology 7, 715-726, 2011 | 1003 | 2011 |
| Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs TF Lüscher, M Barton Circulation 102 (19), 2434-2440, 2000 | 947 | 2000 |
| Estrogen biology: new insights into GPER function and clinical opportunities ER Prossnitz, M Barton Molecular and Cellular Endocrinology 389 (1-2), 71-83, 2014 | 467 | 2014 |
| Endothelin: 20 years from discovery to therapy M Barton, M Yanagisawa Canadian Journal of Physiology and Pharmacology 86 (8), 485-498, 2008 | 455 | 2008 |
| Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ETA-receptor antagonist P Moreau, LV d'Uscio, S Shaw, H Takase, M Barton, TF Lüscher Circulation 96 (5), 1593-1597, 1997 | 450 | 1997 |
| Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice M Barton, CC Haudenschild, LV d’Uscio, S Shaw, K Münter, TF Lüscher Proceedings of the National Academy of Sciences 95 (24), 14367-14372, 1998 | 445 | 1998 |
| Regulatory role of G protein–coupled estrogen receptor for vascular function and obesity E Haas, I Bhattacharya, E Brailoiu, M Damjanović, GC Brailoiu, X Gao, ... Circulation Research 104 (3), 288-291, 2009 | 436 | 2009 |
| Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors MR Meyer, DJ Clegg, ER Prossnitz, M Barton Acta Physiologica 203 (1), 259-269, 2011 | 366 | 2011 |
| Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. MR Tschudi, M Barton, NA Bersinger, P Moreau, F Cosentino, G Noll, ... Journal of Clinical Investigation 98 (4), 899-905, 1996 | 358 | 1996 |
| Postmenopausal hypertension: mechanisms and therapy M Barton, MR Meyer Hypertension 54 (1), 11-18, 2009 | 355 | 2009 |
| Endothelin and endothelin antagonists in chronic kidney disease DE Kohan, M Barton Kidney International 86 (5), 896-904, 2014 | 318 | 2014 |
| Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen RK Dubey, B Imthurn, M Barton, EK Jackson Cardiovascular Research 66 (2), 295-306, 2005 | 316 | 2005 |
| Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin M Barton, F Cosentino, RP Brandes, P Moreau, S Shaw, TF Lüscher Hypertension 30 (4), 817-824, 1997 | 312 | 1997 |
| Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro A Mügge, M Riedel, M Barton, M Kuhn, PR Lichtlen Cardiovascular Research 27 (11), 1939-1942, 1993 | 308 | 1993 |
| Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation M Barton, S Shaw, LV d'Uscio, P Moreau, TF Lüscher Biochemical and Biophysical Research Communications 238 (3), 861-865, 1997 | 272 | 1997 |
| Twenty years of the G protein-coupled estrogen receptor GPER: historical and personal perspectives M Barton, EJ Filardo, SJ Lolait, P Thomas, M Maggiolini, ER Prossnitz The Journal of Steroid Biochemistry and Molecular Biology 176, 4-15, 2018 | 261 | 2018 |
| Endothelin: 30 years from discovery to therapy M Barton, M Yanagisawa Hypertension 74 (6), 1232–1265, 2019 | 246 | 2019 |
| ETA receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension M Barton, LV d’Uscio, S Shaw, P Meyer, P Moreau, TF Lüscher Hypertension 31 (1), 499-504, 1998 | 215 | 1998 |
| Differential effects of 17β-estradiol on function and expression of estrogen receptor α, estrogen receptor β, and GPR30 in arteries and veins of patients with atherosclerosis E Haas, MR Meyer, U Schurr, I Bhattacharya, R Minotti, HH Nguyen, ... Hypertension 49 (6), 1358-1363, 2007 | 214 | 2007 |
